EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A multicentral prospective cohort trial of a pharmacist-led nutritional intervention on serum potassium levels in outpatients with chronic kidney disease: The MieYaku-Chronic Kidney Disease project

Yuki Asai iD, Asami Muramatsu, Tatsuya Kobayashi, Ikuhiro Takasaki, Toshiki Murasaka, Ai Izukawa, Kahori Miyada, Takahiro Okazaki, Tatsuki Yanagawa, Yasuharu Abe, Yasushi Takai, Takuya Iwamoto

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304479 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuki Asai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Potassium, Outpatients, Pharmacists. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Pharmaceutical Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although dietary potassium restriction is an acceptable approach to hyperkalemia prevention, it may be insufficient for outpatients with chronic kidney disease (CKD). Most outpatients with CKD use community pharmacies owing to the free access scheme in Japan. The MieYaku-CKD project included a community pharmacist-led nutritional intervention for dietary potassium restriction, with the goal of determining its efficacy for patients’ awareness of potassium restriction and serum potassium levels in outpatients with CKD. This was a five-community pharmacy multicenter prospective cohort study with an open-label, before-and-after comparison design. Eligible patients (n = 25) with an estimated glomerular filtration rate (eGFR) < 45 mL/min/1.73 m 2 received nutritional guidance from community pharmacists. The primary outcome was a change in serum potassium levels at 12 weeks post-intervention. The eligible patients’ knowledge, awareness, and implementation of potassium restriction were evaluated using a questionnaire. The median value of serum potassium was significantly reduced from 4.7 mEq/L before to 4.4 mEq/L after the intervention [ p < 0.001, 95% confidence interval (CI): 0.156–0.500], with no changes in eGFR ( p = 0.563, 95% CI: -2.427–2.555) and blood urine nitrogen/serum creatinine ratio ( p = 0.904, 95% CI: -1.793–1.214). The value of serum potassium had a tendency of attenuation from 5.3 to 4.6 mEq/L ( p = 0.046, 95% CI: 0.272–1.114) in the eGFR < 30 mL/min/1.73 m 2 group. A questionnaire revealed that after the intervention, knowledge and attitudes regarding dietary potassium restriction were much greater than before, suggesting that the decrease in serum potassium levels may be related to this nutritional guidance. Our findings indicate that implementing a dietary potassium restriction guidance program in community pharmacies is feasible and may result in lower serum potassium levels in outpatients with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicPotassiumOutpatientsPharmacistsGlomerular Filtration RateHumansFemaleMaleProspective StudiesAgedMiddle AgedJapanHyperkalemiaPotassium, DietaryAged, 80 and over

Substanzen

PotassiumPotassium, Dietary

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University, Tsu, Mie, Japan.
  • Pharmacy, National Hospital Organization Mie Chuo Medical Center, Tsu, Mie, Japan.
  • Nutrition Management Office, National Hospital Organization Mie Chuo Medical Center, Tsu, Mie, Japan.
  • Mie Pharmaceutical Association Kaiei Hisai Dispensing Pharmacy, Tsu, Mie, Japan.
  • Hisai Center Pharmacy, Tsu, Mie, Japan.
  • Konan Pharmacy, Tsu, Mie, Japan.

ORCID-Profile: Yuki Asai

Förderung

  • Japan Pharmaceutical Association

Zitieren

APA

Asai, Y., Muramatsu, A., Kobayashi, T., Takasaki, I., Murasaka, T., Izukawa, A., Miyada, K., Okazaki, T., Yanagawa, T., Abe, Y., Takai, Y., & Iwamoto, T. (2024). A multicentral prospective cohort trial of a pharmacist-led nutritional intervention on serum potassium levels in outpatients with chronic kidney disease: The MieYaku-Chronic Kidney Disease project. PLOS ONE. https://doi.org/10.1371/journal.pone.0304479

Vancouver

Asai Y, Muramatsu A, Kobayashi T, Takasaki I, Murasaka T, Izukawa A, et al. A multicentral prospective cohort trial of a pharmacist-led nutritional intervention on serum potassium levels in outpatients with chronic kidney disease: The MieYaku-Chronic Kidney Disease project. PLOS ONE. 2024. doi:10.1371/journal.pone.0304479

BibTeX
@article{Asai2024,
  author = {Asai, Yuki and Muramatsu, Asami and Kobayashi, Tatsuya and Takasaki, Ikuhiro and Murasaka, Toshiki and Izukawa, Ai and Miyada, Kahori and Okazaki, Takahiro and Yanagawa, Tatsuki and Abe, Yasuharu and Takai, Yasushi and Iwamoto, Takuya},
  title = {A multicentral prospective cohort trial of a pharmacist-led nutritional intervention on serum potassium levels in outpatients with chronic kidney disease: The MieYaku-Chronic Kidney Disease project},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304479}
}
Kostenlos starten →